Shamrock Clinical Trial Opens

This is a hugely significant trial for patients with early phase Her-2 positive breast cancer, and one that we’re able to fund through the extraordinary support of those who participated in our Pink Run events in 2022 & 2023. It represents the very best in bench-to-bedside translational research which will help transform the landscape of this disease into the future #ResearchMatters

Share This Article